483Jan 25, 2017

483 Document: Spirit Pharmaceuticals


FDANews 483 Spirit Pharmaceuticals Jan 25 2017 top
Robert C. Horan FDA Investigator

On Jan 25, 2017, the FDA inspected Spirit Pharmaceuticals's Ronkonkoma site. Explore the inspectional observations.